Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078273 · ClinicalTrials.gov registry record · Phase 2
Indicated Prevention With At-Risk Gamblers
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 225
- Enrollment target
NCT00078273: Completed Phase 2 study, sponsored by University of Washington.
NCT00078273 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 225 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (69% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00078273, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 225 participants
- Enrollment target
Study Summary
The overall purpose of this study is to reduce the prevalence of gambling risk in college students by evaluating the effectiveness of different treatments in reducing gambling behavior and related negative consequences.
Primary Outcome
The 20-item South Oaks Gambling Screen (SOGS) measures gambling involvement and problem severity based on DSM-III-R pathological gambling criteria.
Interventions
- BEHAVIORAL Personalized Feedback Intervention
- BEHAVIORAL Cognitive Behavioral Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2003-07 |
| Est. Completion | 2003-07 |
| Phase | Phase 2 |
What the finished NCT00078273 record still lists
NCT00078273 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (69% higher).
The record links to 0 conditions, and to 2 interventions - of which Personalized Feedback Intervention is the first listed.
NCT00078273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00078273 about?
NCT00078273 is a clinical study titled "Indicated Prevention With At-Risk Gamblers". The overall purpose of this study is to reduce the prevalence of gambling risk in college students by evaluating the effectiveness of different treatments in reducing gambling behavior and related negative consequences.
What is the current status of trial NCT00078273?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 225 participants. The study started on 2003-07. Estimated completion is 2003-07.
What interventions are being tested in trial NCT00078273?
The interventions under investigation include: Personalized Feedback Intervention (BEHAVIORAL), Cognitive Behavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00078273?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00078273's enrollment target sits among peer trials
225 267th of 2000 higher than 1,732 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia